Waters Corporation

Executive Summary

Waters Corporation is a leading provider of high-performance analytical instruments, software, and services, with core expertise in liquid chromatography, mass spectrometry, and thermal analysis. Serving pharmaceutical, life sciences, industrial, clinical, and food safety markets, Waters' solutions are critical for drug discovery, biopharmaceutical characterization, and quality control. The company's direct sales and service network spans global markets, and its informatics platforms enable complex data management and interpretation. With a market capitalization of approximately $30 billion, Waters continues to benefit from secular trends in precision medicine, biopharma R&D, and laboratory digitization. However, near-term growth has been tempered by macroeconomic headwinds in China and cautious spending by pharma customers.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation mass spectrometry platform80% success
• Q4 2026Recovery in China demand as stimulus measures take effect60% success
• Q2 2026Potential bolt-on acquisition to expand bioprocessing portfolio50% success